Determination of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy
PDF

Keywords

diffuse reflectance spectroscopy
atenolol
p-chloranil
pharmaceutical formulations

How to Cite

Gotardo, M. A., Sequinel, R., Pezza, L., & Pezza, H. R. (2008). Determination of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy. Eclética Química, 33(4), 07–12. https://doi.org/10.26850/1678-4618eqj.v33.4.2008.p07-12

Abstract

A simple analytical method for quantification of atenolol in pharmaceutical formulations by diffuse reflectance spectroscopy is described. The method is based on the reaction, on the filter paper surface, between the drug and p-chloranil producing a colored compound. The best reaction conditions were obtained with 20 μL of atenolol solution and 20 μL of p-chloranil. All reflectance measurements were carried out at 550 nm and the linear range was from 1.13x10-2 to 7.88x10-2 mol L-1 (r = 0.9992). The limit of detection was 2.80 x 10-3 mol L-1. The proposed method was successfully applied to analysis of different commercial brands of pharmaceutical formulations and the results obtained by the proposed method were in good agreement with those obtained using the British Pharmacopoeia method.

https://doi.org/10.26850/1678-4618eqj.v33.4.2008.p07-12
PDF

References

E. C. Vidotti, W. F. Costa, and C. C. Oliveira, Talanta, 68

(2005) 516.

P. T. Anasta, Crit. Rev. Anal. Chem., 29 (1999) 167.

K. Pastore, Revista Veja, 31 (1998) 40.

L. Pezza, M. Tubino, C. B. Melios, and H. R. Pezza, Anal.

Sci., 16 (2000) 313.

B. B. Hoffman, in: J. G. Hardman, L. E. Limbird, A. G.

Gilman (eds), Goodman & Goodman¥s The Pharmacological

Basis of Therapeutics, tenth ed., MacGraw-Hill, Rio de

Janeiro, v. 10, 1987, p. 1011-1021.

United States Pharmacopeia: USP 26 the national formulary USP 26-NF1, twenty sixth ed. Rockville, MD, 2003.

British Pharmacopoeia Londom: The Stationer Office, v.

, 2001.

Y. K. Agrawal, K. Raman, S. Raiput, and S. K. Menon,

Anal. Lett., 12 (1992) 1503.

A. Gülcü, C. Yücesoy, and S. Serin, Farmaco, 59 (2004) 487.

H. Salem, J. Pharm. Biomed. Anal., 29 (2002) 527.

S. M. Al-Ghannam and F. Belal, J. AOAC Int., 85 (2002)

A. S. Amin, G. H. Ragab, and H. Saleh, J. Pharm.

Biomed. Anal., 30 (2002) 1347.

S. M. Al-Ghannam, J. Pharm. Biomed. Anal., 40 (2006) 151.

M. C. F. Ferraro, P. M. Castellano, and T. S. Kaufman, J.

Pharm. Biomed. Anal., 34 (2004) 305.

D. Bonazzi, R. Gotti, V. Andrisano, and V. Cavrini,

Farmaco, 51 (1996) 733.

I. R. Martinez, M. C. G. A. Coque, and R. M. V. Camanas, J. Chromatogr., A, 765 (1997) 221.

A. P. Argekar, and J. G. Sawant, J. Liq. Chromatogr. Rel.

Technol., 22 (1999) 1571.

A. P. Argekar, and S.G. Powar, Farmaco, 21 (2000) 1137.

D. P. Nikolelis, S. E. Petropoulou, and M. V. Mitrokotsa,

Bioelectrochemistry, 58 (2002) 107.

S. S. M. Hassan, M. M. Abou-Sekkina, M. A. El-Ries,

and A. A. Wassel, J. Pharm. Biomed. Anal., 32 (2003) 175.

M. Shamsipur, and F. Jalali, Anal. Lett., 38 (2005) 401.

P. S. Bonato, A. C. C. Briguenti, Drug Dev. Ind. Pharm.,

(2005) 209.

A. Shafaati and B. J. Clark, Anal. Lett., 14 (1996) 1547.

M. I. Maguregui, R. M. Jimenez, and R. M. Alonso, J.

Chromatogr. Sci., 36 (1998) 516.

R. N. Goyal, V. K. Gupta, M. Oyama, N. Bachheti,

Electrochem. Commun., 8 (2006) 65.

R. N. Goyal, and S. P. Singh, Talanta, 39 (2006) 932.

M. P. Arena, M. D. Porter, J. S. Fritz, Anal. Chim. Acta,

(2003) 197.

S. G. Dmitrienko, O. A. Sviridova, L. N. Pyatkova, V. M.

Senyavin, Anal. Bioanal. Chem. 374 (2002) 361.

F. A. A. Matias, M. M. D. C. Vila, M. Tubino, Sens.

Actuators B, 88 (2003) 60.

A. Ghauch, C. Turnar, C. Fachinger, J. Rima, A. Charef,

J. Suptil, M. Martin-Bouyer, Chemosphere, 40 (2000) 1327.

Y. Moliner-Martinez, P. Campíns-Falcó, Talanta, 65

(2005) 217.

M. Tubino, R. L. Souza, Talanta, 68 (2006) 776.

O. A. Zaporozhets, O. Gawer, V. Sukhan, Talanta, 46

(1998) 1387.

O. A. Zaporozhets, L. Tsyukalo, Talanta, 58 (2002) 861.

F. A. A. Matias, W. A. Oliveira, E. Moschim, Sens.

Actuators B, 41 (1997) 159.

M. A. Gotardo, A. C. Gigante, L. Pezza, H. R. Pezza,

Talanta, 64 (2004) 361.

M. A. Gotardo, L. Pezza, H. R. Pezza, Eclet. Quim., 30

(2005) 17.

M. Tubino, A. V. Rossi, M. E. A. Magalhães, Anal. Lett.,

(1997) 271.

M. A. Korany, A. A. M. Wahbi, Analyst, 104 (1979) 146.

L. I. Bebawy, N. El-Kousy, J. K. Suddik, and M. Shokry,

J. Pharm. Biomed. Anal., 21 (1999) 33.

E. A. Ibrahim, A. S. Issa, M. A. A. Salam, and M. S.

Mahrous, Talanta, 30 (1983) 531.

R. S. Bakry, O. A. Razak, A. F. M. El-Walily, and S. F.

Belal, J. Pharm. Biomed. Anal., 14 (1996) 357.

H. Salem, J. Pharm. Biomed. Anal., 29 (2002) 527.

R. Foster, Organic Charge-Transfer Complexes, 2nd ed.,

Academic Press, London, 1968, p. 470.

D. A. Skoog, F. J. Holler, T. A. Nieman, Principles of

Instrumental Analysis, fifth ed., Harcourt Brace Company,

Philadelphia, 1998, p. 27.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2018 Eclética Química Journal

Metrics

PDF views
117
Jan 2009Jul 2009Jan 2010Jul 2010Jan 2011Jul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 202615
|